TickerFactsScreenerDevelopers

REGENERON PHARMACEUTICALS, INC. (REGN) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2007: $498.93M2008: $247.80M2009: $207.07M2010: $112.57M2011: $483.61M2012: $230.28M2013: $535.61M2014: $648.72M2015: $809.10M2016: $535.20M2017: $812.70M2018: $1.47B2019: $1.62B2020: $2.19B2021: $2.89B2022: $3.11B2023: $2.73B2024: $2.49B2025: $3.12B$3.12B
2007Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$3.12B+25.3%
2024$2.49B-8.9%
2023$2.73B-12.1%
2022$3.11B+7.6%
2021$2.89B+31.5%
2020$2.19B+35.6%
2019$1.62B+10.2%
2018$1.47B+80.6%
2017$812.70M+51.8%
2016$535.20M-33.9%
2015$809.10M+24.7%
2014$648.72M+21.1%
2013$535.61M+132.6%
2012$230.28M-52.4%
2011$483.61M+329.6%
2010$112.57M-45.6%
2009$207.07M-16.4%
2008$247.80M-50.3%
2007$498.93M—